symptomatic nOH
Showing 1 - 25 of 4,639
Symptomatic Neurogenic Orthostatic Hypotension, MSA - Multiple System Atrophy Trial (Ampreloxetine, Placebo)
Not yet recruiting
- Symptomatic Neurogenic Orthostatic Hypotension
- MSA - Multiple System Atrophy
- Ampreloxetine
- Placebo
- (no location specified)
Jan 13, 2023
Symptomatic Neurogenic Orthostatic Hypotension Trial in Worldwide (ampreloxetine)
Terminated
- Symptomatic Neurogenic Orthostatic Hypotension
-
Colorado Springs, Colorado
- +54 more
Nov 7, 2022
Symptomatic Neurogenic Orthostatic Hypertension, nOH Trial in Miami, Orlando (Ampreloxetine)
Completed
- Symptomatic Neurogenic Orthostatic Hypertension
- nOH
-
Miami, Florida
- +1 more
Sep 7, 2021
Symptomatic Neurogenic Orthostatic Hypertension, nOH Trial in Tempe (Ampreloxetine <Dose A>, Ampreloxetine <Dose B>,
Completed
- Symptomatic Neurogenic Orthostatic Hypertension
- nOH
- Ampreloxetine <Dose A>
- +4 more
-
Tempe, ArizonaTheravance Biopharma Investigational Site
Apr 19, 2021
Symptomatic Neurogenic Orthostatic Hypotension, MSA, Parkinson's Disease (PD) Trial in Worldwide (ampreloxetine, Placebo)
Terminated
- Symptomatic Neurogenic Orthostatic Hypotension
- +3 more
- ampreloxetine
- Placebo
-
Sun City, Arizona
- +81 more
Dec 29, 2022
Symptomatic Neurogenic Orthostatic Hypotension Trial in Worldwide (ampreloxetine, Placebo)
Completed
- Symptomatic Neurogenic Orthostatic Hypotension
- ampreloxetine
- Placebo
-
Sun City, Arizona
- +124 more
Sep 15, 2021
Degenerative Osteoarthritis Trial (TG-C, Placebo Control)
Not yet recruiting
- Degenerative Osteoarthritis
- TG-C
- Placebo Control
- (no location specified)
Dec 22, 2022
Neurogenic Orthostatic Hypotension, Autonomic Failure Trial in Calgary (CO2 ReHaler)
Not yet recruiting
- Neurogenic Orthostatic Hypotension
- Autonomic Failure
- CO2 ReHaler
-
Calgary, Alberta, CanadaUniversity of Calgary
Jun 16, 2023
Orthostatic Hypotension, Neurogenic Orthostatic Hypotension Trial in Calgary (Sequential Gas Delivery)
Recruiting
- Orthostatic Hypotension
- Neurogenic Orthostatic Hypotension
- Sequential Gas Delivery
-
Calgary, Alberta, CanadaUniversity of Calgary
Oct 31, 2022
Neurogenic Orthostatic Hypotension Trial in Hackensack (Sinosuidal Galvanic Vestibular Stimulation, Placebo)
Not yet recruiting
- Neurogenic Orthostatic Hypotension
- Sinosuidal Galvanic Vestibular Stimulation
- Placebo
-
Hackensack, New JerseyHackensack Univeristy Medical Center
May 6, 2022
Neurogenic Orthostatic Hypotension Trial in New York, Nashville (Atomoxetine, Placebo)
Completed
- Multiple System Atrophy (MSA)
- Atomexetine
- Placebo
-
New York, New YorkNew York University School of Medicine
Jan 4, 2022
Neurogenic Orthostatic Hypotension, Multiple System Atrophy (MSA) With Orthostatic Hypotension, Pure Autonomic Failure Trial in
Completed
- Neurogenic Orthostatic Hypotension
- +7 more
- TD-9855
- Placebo
-
Long Beach, California
- +5 more
Aug 30, 2022
History of Myocardial Infarction Trial in Boston (18F-FDG PET/CT)
Recruiting
- History of Myocardial Infarction
- 18F-FDG PET/CT
-
Boston, MassachusettsMassachusetts General Hospital, Havard Medical School
Nov 30, 2021
Degenerative Osteoarthritis Trial in United States (TG-C, Placebo Control)
Recruiting
- Degenerative Osteoarthritis
- TG-C
- Placebo Control
-
Birmingham, Alabama
- +34 more
Dec 23, 2022
Mitral Valve Insufficiency Trial (DragonFly Transcatheter Mitral Valve Repair System)
Not yet recruiting
- Mitral Valve Insufficiency
- DragonFly Transcatheter Mitral Valve Repair System
- (no location specified)
Jun 30, 2023
Quality of Life of the Symptomatic Convergence Insufficiency
Recruiting
- Myopia
- Convergence Insufficiency
- Visual training in hospital
-
Tianjin, ChinaTianjin Eye Hospital
Jul 13, 2023
Revitalization of Traumatized Immature Permanent Teeth
Recruiting
- Apical Periodontitis
- Trauma
- revitalization
-
Ghent, BelgiumGhent University
Sep 12, 2023
Ureteral Stone Trial in San Francisco (Ureteroscopy)
Not yet recruiting
- Ureteral Stone
- Ureteroscopy
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 2, 2023
Cutaneous Nerves CNS Itch Trial in Minneapolis (Clonidine, Naltrexone)
Completed
- Cutaneous Nerves CNS Itch
-
Minneapolis, MinnesotaUniversity of Minnesota Department of Dermatology
Jan 23, 2023
Schizophrenia Trial in Taichung (NMDAE, Placebo Cap)
Not yet recruiting
- Schizophrenia
- NMDAE
- Placebo Cap
-
Taichung, TaiwanDepartment of Psychiatry, China Medical University Hospital
Sep 4, 2023
Quality of Life Following Rectal Artery Embolization for
Recruiting
- Internal Hemorrhoid
- Rectal Artery Embolization
-
Rochester, MinnesotaMayo Clinic Minnesota
Oct 24, 2023
Multiple System Atrophy Trial in France (L-Threo DOPS, )
Completed
- Multiple System Atrophy
- L-Threo DOPS
- placebo
-
Angers, France
- +12 more
Aug 24, 2020
Carpal Tunnel Syndrome, CTS Trial in Lexington (Ultrasound Guided Carpal Tunnel Release (CTR-US))
Not yet recruiting
- Carpal Tunnel Syndrome
- CTS
- Ultrasound Guided Carpal Tunnel Release (CTR-US)
-
Lexington, KentuckyBluegrass Orthopaedics
Oct 4, 2023
Chronic Coronary Syndrome, Myocardial Ischemia, Stable Angina Trial in Herning (Optimization of guideline-directed medical
Recruiting
- Chronic Coronary Syndrome
- +3 more
- Optimization of guideline-directed medical therapy
- +3 more
-
Herning, Central Denmark Region, DenmarkGødstrup Hospital
May 23, 2023
Parkinson Disease, Multiple System Atrophy, Progressive Supranuclear Palsy Trial in Loma Linda (Droxidopa, Placebo Oral Tablet)
Withdrawn
- Parkinson Disease
- +2 more
- Droxidopa
- Placebo Oral Tablet
-
Loma Linda, CaliforniaLoma Linda University Faculty Medical Offices - Neurology Clinic
Feb 14, 2022